Home » Topics » Disease categories and therapies » Immune

Immune
RSS

MeNZB meningococcal B vaccine approved in New Zealand

July 9, 2004

trans-ISA-247 completes single ascending dose study

July 9, 2004

ZymoGenetics licenses to Novo Nordisk rights to IL-28A, IL-29 and IL-31

July 8, 2004

ID Biomedical's acquisition of Shire's vaccine business nears completion

July 5, 2004

Selective glucocorticoid receptor modulator may prevent progression of multiple sclerosis

July 2, 2004

Immunization completed in phase I ragweed allergy immunotherapy study

July 1, 2004

Two series of immunomodulating agents newly described by BMS scientists

July 1, 2004

Novel monoclonal antibody promising against graft rejection

June 30, 2004

Vertex scientists prepare and test new inhibitors of JAK, JNK, CDK, etc.

June 29, 2004

Preclinical studies on possible effects of anti-human Fas antibody R-125224 in autoimmune diseases

June 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...